Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts NextSource Materials July 26, 2025 Editor’s Picks: Miners Rescued, US Mine Waste Strategy, Ontario Expands CIMF July 26, 2025 Pinnacle Increases Non-Brokered Private Placement July 26, 2025